These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14012221)

  • 21. BLOOD CONCENTRATIONS OF PAS PRODUCED BY A MIXTURE OF PAS AND THE PHENYL ESTER OF PAS.
    MORRIS D
    Tubercle; 1963 Dec; 44():480-3. PubMed ID: 14101329
    [No Abstract]   [Full Text] [Related]  

  • 22. SPECTROPHOTOMETRIC INVESTIGATION OF ISONICOTINOYL HYDRAZIDE (INH). A CONTRIBUTION TO THE KNOWLEDGE OF THE YELLOW ISONICOTINOYL HYDRAZIDE RHO-AMINOSALICYLIC ACID COMBINATION (INH-PAS).
    REKKER RF; NAUTA WT
    Pharm Weekbl; 1964 Oct; 99():1157-65. PubMed ID: 14230284
    [No Abstract]   [Full Text] [Related]  

  • 23. [ON TESTS FOR DETERMINING THE PURITY OF PAS SOLUTIONS].
    STEINBACH H
    Tuberkulosearzt; 1963 Dec; 17():761-5. PubMed ID: 14123195
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of massive doses of PAS on renal function and electrolyte balance.
    BRANDER L; KUHLBACK B; NIEMISTO M; RISKA N
    Scand J Clin Lab Invest; 1963; 15 Suppl 69():38-43. PubMed ID: 14041123
    [No Abstract]   [Full Text] [Related]  

  • 25. A CONTROLLED TRIAL OF ISONIAZID AND 4-4 DIISOAMYLOXYTHIOSEMICARBANILIDE COMPARED WITH ISONIAZID AND PAS AND ISONIAZID, STREPTOMYCIN AND PAS.
    OLEJNICEK M; WEBEROVA M; NOVAK M; JANCIK E
    Tubercle; 1965 Jun; 46():188-92. PubMed ID: 14327966
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pharmacokinetics of PAS].
    Khabarov AA; Povaliaeva LI; Novosel'skaia LM
    Farmatsiia; 1977; 26(4):49-50. PubMed ID: 902798
    [No Abstract]   [Full Text] [Related]  

  • 27. [Considerations on the behavior of blood and CSF concentrations in children subjected to the introduction of PAS by various routes].
    CARNEVALE A; CUTILLO S
    Pediatria (Rio); 1949; 57(5-6):365-72. PubMed ID: 18137830
    [No Abstract]   [Full Text] [Related]  

  • 28. [Considerations on a case of purpura in a tuberculous patient treated with streptomycin and PAS].
    POPPA C; POPA I; ENACHE F
    Med Interna (Bucur); 1963 Jan; 15():93-6. PubMed ID: 13972297
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of antitubercular agents, especially PAS, on the serum cholesterol level in pulmonary tuberculosis].
    KAGEURA K
    Nagasaki Igakkai Zasshi; 1963 Jan; 38():54-81. PubMed ID: 13958259
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experiments on selection of Mycobacterium avium under the influence of INH and PAS].
    KIELWEIN G
    Zentralbl Bakteriol; 1963 Mar; 188():371-6. PubMed ID: 14042162
    [No Abstract]   [Full Text] [Related]  

  • 31. An evaluation of surveillance methods for self-medication with isoniazid and para-aminosalicylic acid in tuberculous patients.
    HUEMPFNER HR; ZAPOLSKY I; KENNEDY JA; DEUSCHLE KW
    Am Rev Respir Dis; 1963 Jun; 87():844-51. PubMed ID: 13955482
    [No Abstract]   [Full Text] [Related]  

  • 32. [ON THE EFFECT OF PAS ON THE SECRETORY ACTIVITY OF THE STOMACH IN PATIENTS WITH TUBERCULOSIS OF THE LUNGS].
    PASHCHENKO IG
    Probl Tuberk; 1964; 42():61-6. PubMed ID: 14173695
    [No Abstract]   [Full Text] [Related]  

  • 33. [VARIATION IN THE PRICE OF PAS PREPARATIONS AND ITS EFFECT ON THE TOTAL EXPENSES OF ANTITUBERCULAR TREATMENT].
    HAAPANEN JH; PIKKOLA E
    Duodecim; 1964; 80():551-3. PubMed ID: 14169996
    [No Abstract]   [Full Text] [Related]  

  • 34. The intravenous administration of p-aminosalicylic acid.
    BARCLAY WR
    Am Rev Tuberc; 1949 Sep; 60(3):385. PubMed ID: 18228777
    [No Abstract]   [Full Text] [Related]  

  • 35. [STUDIES ON THE INFLUENCE OF MAGNESIUM COMPOUNDS ON THE METABOLISM OF PAS. 1. INTESTINAL ABSORPTION OF PAS AND MAGNESIUM COMPOUNDS].
    YOSHINARI S
    Nihon Yakurigaku Zasshi; 1964 Sep; 60():399-405. PubMed ID: 14271231
    [No Abstract]   [Full Text] [Related]  

  • 36. [SUPPLEMENTARY INFORMATION ON THE ANTITUBERCULAR ACTION OF PAS-PHENYLESTERS].
    MAEKAWA N; TSUKUMA S; SHIMIZU A; KAWAI M; NAKAI J; KUZE F; OZAWA A
    Kyoto Daigaku Kekkaku Kenkyusho Kiyo; 1964 Mar; 12():89-96. PubMed ID: 14161659
    [No Abstract]   [Full Text] [Related]  

  • 37. [Benzacyl & PAS in therapy of pulmonary tuberculosis; a comparison].
    STAHLE I
    Sven Lakartidn; 1957 Jul; 54(27):2125-37. PubMed ID: 13455539
    [No Abstract]   [Full Text] [Related]  

  • 38. TWENTY YEARS AFTERWARD HISTORICAL NOTES ON THE DISCOVERY OF THE ANTITUBERCULOSIS EFFECT OF PARAAMINOSALICYLIC ACID (PAS) AND THE FIRST CLINICAL TRIALS.
    LEHMANN J
    Am Rev Respir Dis; 1964 Dec; 90():953-6. PubMed ID: 14233801
    [No Abstract]   [Full Text] [Related]  

  • 39. Para-aminosalicylic acid-induced hypoglycaemia in a patient with diabetic nephropathy.
    Dandona P; Greenbury E; Beckett AG
    Postgrad Med J; 1980 Feb; 56(652):135-6. PubMed ID: 7393795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [ETHIONAMIDE ASSOCIATED WITH CYCLOSERINE OR PAS IN PERFUSION IN THE TREATMENT OF CHRONIC PULMONARY TUBERCULOSIS].
    BARONI V
    G Ital Chemioter; 1963; 10():133-41. PubMed ID: 14074250
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.